Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Tamai, Katsuto  [Clear All Filters]
2023
Kogetsu A, Isono M, Aikyo T, Furuta J, Goto D, Hamakawa N, Hide M, Hori R, Ikeda N, Inoi K, et al. Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan. Res Involv Engagem. 2023;9(1):107.
Kikuchi Y, Tamakoshi T, Ishida R, Kobayashi R, Mori S, Ishida-Yamamoto A, Fujimoto M, Kaneda Y, Tamai K. Gene-modified blister fluid-derived mesenchymal stromal cells for treating recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2023.
Hara T, Shimbo T, Masuda T, Kitayama T, Fujii M, Hanawa M, Yokota K, Endo M, Tomimatsu T, Kimura T, et al. High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model. Biochem Biophys Res Commun. 2023;671:357-365.
Tamai K. Letter to the late Professor Jouni Uitto. J Dermatol Sci. 2023.
2022
Ishii Y, Tsuchiya A, Natsui K, Koseki Y, Takeda N, Tomiyoshi K, Yamazaki F, Yoshida Y, Shimbo T, Tamai K, et al. Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a nonalcoholic steatohepatitis mouse model. Hepatol Res. 2022.
2021
Ho Y-T, Shimbo T, Wijaya E, Kitayama T, Takaki S, Ikegami K, Miyashita K, Ouchi Y, Takaki E, Yamamoto R, et al. Longitudinal single cell transcriptomics reveals a role for Serpina3n-mediated resolution of inflammation in a mouse colitis model. Cell Mol Gastroenterol Hepatol. 2021.
2020
Goto T, Miyagawa S, Tamai K, Matsuura R, Kido T, Kuratani T, Shimamura K, Sakaniwa R, Harada A, Sawa Y. High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells. PLoS One. 2020;15(4):e0230392.
2018
Kido T, Miyagawa S, Goto T, Tamai K, Ueno T, Toda K, Kuratani T, Sawa Y. The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster. PLoS One. 2018;13(12):e0202838.
2015
Takahashi K, Endo M, Miyoshi T, Tsuritani M, Shimazu Y, Hosoda H, Saga K, Tamai K, Flake AW, Yoshimatsu J, et al. Immune Tolerance Induction Using Fetal Directed Placental Injection in Rodent Models: A Murine Model. PLoS One. 2015;10(4):e0123712.